BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16630992)

  • 1. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
    Kardys I; Klaver CC; Despriet DD; Bergen AA; Uitterlinden AG; Hofman A; Oostra BA; Van Duijn CM; de Jong PT; Witteman JC
    J Am Coll Cardiol; 2006 Apr; 47(8):1568-75. PubMed ID: 16630992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
    Kardys I; de Maat MP; Klaver CC; Despriet DD; Uitterlinden AG; Hofman A; de Jong PT; Witteman JC
    Am J Cardiol; 2007 Aug; 100(4):646-8. PubMed ID: 17697822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors.
    Stark K; Neureuther K; Sedlacek K; Hengstenberg W; Fischer M; Baessler A; Wiedmann S; Jeron A; Holmer S; Erdmann J; Schunkert H; Hengstenberg C
    Clin Sci (Lond); 2007 Aug; 113(4):213-8. PubMed ID: 17472578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women.
    Pai JK; Manson JE; Rexrode KM; Albert CM; Hunter DJ; Rimm EB
    Eur Heart J; 2007 Jun; 28(11):1297-303. PubMed ID: 17483111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study.
    Sayed-Tabatabaei FA; Schut AF; Arias Vásquez A; Bertoli-Avella AM; Hofman A; Witteman JC; van Duijn CM
    J Med Genet; 2005 Jan; 42(1):26-30. PubMed ID: 15635071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
    Li YH; Chen JH; Tsai WC; Chao TH; Guo HR; Tsai LM; Wu HL; Shi GY
    Thromb Haemost; 2002 Jan; 87(1):86-91. PubMed ID: 11848462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study.
    Isaacs A; Sayed-Tabatabaei FA; Hofman A; Oostra BA; Klungel OH; Maitland-Vander Zee AH; Stricker BH; Witteman JC; van Duijn CM
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):419-21. PubMed ID: 17568242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factor H polymorphism in age-related macular degeneration.
    Narayanan R; Butani V; Boyer DS; Atilano SR; Resende GP; Kim DS; Chakrabarti S; Kuppermann BD; Khatibi N; Chwa M; Nesburn AB; Kenney MC
    Ophthalmology; 2007 Jul; 114(7):1327-31. PubMed ID: 17306880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
    Mooijaart SP; Koeijvoets KM; Sijbrands EJ; Daha MR; Westendorp RG
    Exp Gerontol; 2007 Nov; 42(11):1116-22. PubMed ID: 17869048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classical risk factors for myocardial infarction and total mortality in the community--13-year follow-up of the MONICA Augsburg cohort study].
    Heidrich J; Wellmann J; Hense HW; Siebert E; Liese AD; Löwel H; Keil U
    Z Kardiol; 2003 Jun; 92(6):445-54. PubMed ID: 12819993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
    Yue H; Gu DF; Wu XG; Yu XH; Duan XF; Wang JH; Zheng RP; Zhou J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):43-6. PubMed ID: 14989905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men.
    Ridker PM; Baker MT; Hennekens CH; Stampfer MJ; Vaughan DE
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1687-90. PubMed ID: 9327764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
    Aubó C; Sentí M; Marrugat J; Tomás M; Vila J; Sala J; Masiá R
    Eur Heart J; 2000 Jan; 21(1):33-8. PubMed ID: 10610741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction.
    Blaskó B; Kolka R; Thorbjornsdottir P; Sigurdarson ST; Sigurdsson G; Rónai Z; Sasvári-Székely M; Bödvarsson S; Thorgeirsson G; Prohászka Z; Kovács M; Füst G; Arason GJ
    Int Immunol; 2008 Jan; 20(1):31-7. PubMed ID: 18032375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
    Haffner SM; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    N Engl J Med; 1998 Jul; 339(4):229-34. PubMed ID: 9673301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study.
    Brugts JJ; Knetsch AM; Mattace-Raso FU; Hofman A; Witteman JC
    Arch Intern Med; 2005 Dec 12-26; 165(22):2659-65. PubMed ID: 16344425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.